SciVision Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	677.8	845.81	706.02	511.1	587.02	658.92
Short-Term Investments	49.9	79.9	99.9	233.9	30.71	36.92
Cash & Short-Term Investments	727.7	925.71	805.92	745	617.73	695.84
Cash Growth	13.30%	14.86%	8.18%	20.60%	-11.23%	68.36%
Accounts Receivable	220.38	242.14	172.94	95.18	90.34	78.37
Other Receivables	7.8	1.56	1.09	1.02	1.16	0.2
Receivables	228.17	243.7	174.02	96.21	91.49	78.56
Inventory	90.55	82.15	72.23	87.25	95.87	82.9
Prepaid Expenses	74.44	46.39	47.94	15.48	18.65	21.7
Other Current Assets	178.47	129.23	66.3	59.97	57.29	46.24
Total Current Assets	1,299	1,427	1,166	1,004	881.03	925.24
Property, Plant & Equipment	1,196	1,228	1,176	1,135	1,184	1,246
Other Intangible Assets	1.47	1.4	1.68	2.15	2.67	3.38
Long-Term Deferred Tax Assets	5.7	7.14	5.02	15.5	25.04	31.33
Other Long-Term Assets	5.9	6.2	5.01	3.22	5.23	56.48
Total Assets	2,508	2,670	2,354	2,160	2,098	2,262
Accounts Payable	22.05	16.4	13.27	6.75	14.02	5.46
Accrued Expenses	131.46	113.91	135.76	102.56	78.4	-
Short-Term Debt	-	0.51	-	-	-	-
Current Portion of Long-Term Debt	-	-	134.79	-	-	303.37
Current Portion of Leases	10.29	10.18	4.73	1.22	1.2	1.24
Current Income Taxes Payable	7.55	2.39	12.65	5.77	13.97	-
Current Unearned Revenue	2.86	1.55	2.68	7.02	0.7	1.71
Other Current Liabilities	26.85	29.71	33.19	21.69	19.79	113.86
Total Current Liabilities	201.05	174.65	337.07	144.99	128.08	425.64
Long-Term Debt	378.56	373.59	-	323.84	386.69	300
Long-Term Leases	96.76	100.86	84.72	22.85	24.1	28.48
Pension & Post-Retirement Benefits	3.93	6.41	8.14	18.92	25.47	35.16
Long-Term Deferred Tax Liabilities	3.12	0.49	4.35	0.03	0.05	-
Other Long-Term Liabilities	37.62	33.35	23.15	23.03	22.91	22.78
Total Liabilities	721.03	689.35	457.43	533.67	587.31	812.06
Common Stock	748.28	748.28	717.92	677.1	661.9	661.9
Additional Paid-In Capital	960.31	960.31	844.08	700.34	648.26	638.12
Retained Earnings	186.24	272.47	335.25	249.73	201.61	150.72
Treasury Stock	-107.06	-	-	-	-	-
Comprehensive Income & Other	-0.75	-0.82	-0.2	-0.66	-0.84	-0.86
Shareholders' Equity	1,787	1,980	1,897	1,627	1,511	1,450
Total Liabilities & Equity	2,508	2,670	2,354	2,160	2,098	2,262
Total Debt	485.61	485.13	224.24	347.91	411.99	633.09
Net Cash (Debt)	242.09	440.57	581.69	397.09	205.74	62.75
Net Cash Growth	-40.07%	-24.26%	46.49%	93.01%	227.89%	-31.96%
Net Cash Per Share	3.15	5.73	7.81	5.19	2.76	0.88
Filing Date Shares Outstanding	74.83	74.83	71.79	67.71	66.19	66.19
Total Common Shares Outstanding	74.83	74.83	71.79	67.71	66.19	66.19
Working Capital	1,098	1,253	829.35	858.92	752.95	499.6
Book Value Per Share	23.88	26.46	26.42	24.02	22.83	21.90
Tangible Book Value	1,786	1,979	1,895	1,624	1,508	1,446
Tangible Book Value Per Share	23.86	26.45	26.40	23.99	22.79	21.85
Land	4.73	4.73	4.73	4.73	4.73	9.5
Buildings	698.86	689.26	687.72	686.59	686.32	688.54
Machinery	1,047	1,031	926.47	909.63	896.45	891.02
Construction In Progress	2.65	17.68	20.57	3.5	4.62	0.77